Chokanan Thaitirarot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chokanan Thaitirarot has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Shirley Sze
Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
3 shared publications Shirley Sze
Cardiology Department, Glenfield Hospital, Leicester, UK
2 shared publicationsAhmed Hafez
Department of Cardiology, Glenfield Hospital, University Hospitals of Leicester , Leicester LE3 9QP
1 shared publicationAndrew Chan
Cardiology Department, Glenfield Hospital, Leicester, UK
1 shared publication- Clare J. Taylor
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
1 shared publication - Clive Lewis
Transplant Unit, Royal Papworth Hospital, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
Risk prediction models for detecting a new diagnosis of heart failure within 5 years in the community: a systematic review
Objectives: Earlier heart failure (HF) diagnosis in the community could allow timely treatment initiation and prevent unnecessary hospitalisation, but identifying those at risk remains challenging. We aimed to summarise the performance of risk prediction models for a new diagnosis of HF. Design: Systematic review of multivariable incident HF risk prediction models in the community setting. Data sources: MEDLINE and Embase were searched from inception to 9 November 2023. Eligibility criteria: Observational, community-based studies reporting prediction model performance for incident HF within a 5-year time horizon. Data extraction and synthesis: Two reviewers independently screened and extracted data. Where possible, C-statistics (or area under the receiver operating characteristic curve) with 95% CIs were extracted. Risk of bias was assessed using the Prediction model Risk Of Bias ASsessment Tool and certainty of evidence by the Grading of Recommendations, Assessment, Development and Evaluation. Results: Eighteen studies described 45 prediction models, 27 used traditional statistical methods and 18 applied machine learning. Most (39/45) demonstrated acceptable discrimination (C-statistic >0.70). Overall, C-statistics ranged from 0.675 to 0.954, typically with narrow 95% CIs. External validation was performed for 31 models, but only two—the modified PCP-HF models for white men and women—were validated in three cohorts, the highest among all the models. Exploratory random-effects meta-analysis of these models showed pooled C-statistics of 0.82 (95% CI 0.82 to 0.82) for men and 0.85 (95% CI 0.82 to 0.88) for women, indicating excellent discrimination but more heterogenous performance among women. Model performance was at high risk of bias due to unreported or inappropriate handling of missing data, and the certainty of evidence was very low. Conclusion: Risk prediction models for a new diagnosis of HF in the community performed well, but were at high risk of bias and lacked external validation. Future model development requires appropriate data sources, robust handling of missing data, external validation and clinical testing to assess their impact on earlier HF diagnosis and outcomes. PROSPERO registration number: CRD42022347120.
Open AccessRisk prediction models for detecting a new diagnosis of heart failure within 5 years in the community: a systematic review
Objectives: Earlier heart failure (HF) diagnosis in the community could allow timely treatment initiation and prevent unnecessary hospitalisation, but identifying those at risk remains challenging. We aimed to summarise the performance of risk prediction models for a new diagnosis of HF. Design: Systematic review of multivariable incident HF risk prediction models in the community setting. Data sources: MEDLINE and Embase were searched from inception to 9 November 2023. Eligibility criteria: Observational, community-based studies reporting prediction model performance for incident HF within a 5-year time horizon. Data extraction and synthesis: Two reviewers independently screened and extracted data. Where possible, C-statistics (or area under the receiver operating characteristic curve) with 95% CIs were extracted. Risk of bias was assessed using the Prediction model Risk Of Bias ASsessment Tool and certainty of evidence by the Grading of Recommendations, Assessment, Development and Evaluation. Results: Eighteen studies described 45 prediction models, 27 used traditional statistical methods and 18 applied machine learning. Most (39/45) demonstrated acceptable discrimination (C-statistic >0.70). Overall, C-statistics ranged from 0.675 to 0.954, typically with narrow 95% CIs. External validation was performed for 31 models, but only two—the modified PCP-HF models for white men and women—were validated in three cohorts, the highest among all the models. Exploratory random-effects meta-analysis of these models showed pooled C-statistics of 0.82 (95% CI 0.82 to 0.82) for men and 0.85 (95% CI 0.82 to 0.88) for women, indicating excellent discrimination but more heterogenous performance among women. Model performance was at high risk of bias due to unreported or inappropriate handling of missing data, and the certainty of evidence was very low. Conclusion: Risk prediction models for a new diagnosis of HF in the community performed well, but were at high risk of bias and lacked external validation. Future model development requires appropriate data sources, robust handling of missing data, external validation and clinical testing to assess their impact on earlier HF diagnosis and outcomes. PROSPERO registration number: CRD42022347120.
- Open Access
- 21 February 2025
- Published by Elsevier in Clinical Medicine
- Vol. 25 (2) , 100296
Early and rapid initiation of quadruple therapy for heart failure with reduced ejection fraction: A real-world experience
- 21 February 2025
- Published by Elsevier in Clinical Medicine
- Vol. 25 (2) , 100296
Open AccessEarly and rapid initiation of quadruple therapy for heart failure with reduced ejection fraction: A real-world experience
- Open Access
- 1 November 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (11) , ytae546
Takotsubo syndrome induced by de novo left bundle branch area pacing: a case report
Takotsubo syndrome (TS), traditionally associated with emotional or physical stressors, manifests as transient left ventricular (LV) abnormalities mimicking acute coronary syndrome. Surgical procedures, such as pacemaker implantation, have emerged as potential TS triggers. Conduction system pacing (CSP), including His bundle pacing and left bundle branch area pacing (LBBAP), is a novel technique utilizing the heart's intrinsic conduction system. Despite documented cases of TS post-pacemaker implantation, the literature exploring the association between CSP and TS remains sparse. In a case involving a 62-year-old woman with 2:1 atrioventricular block, an uncomplicated de novo LBBAP procedure was followed by post-procedural dizziness and dyspnoea. An initial transthoracic echocardiography revealed moderate–severe LV dysfunction, accompanied by elevated troponin levels. Coronary angiography showed unobstructed coronary arteries, while left ventriculography exhibited a classic apical ballooning. The patient had a favourable recovery, with LV function improvement noted before discharge. Takotsubo syndrome may be triggered by other non-traditional physical stressors including traditional RV pacing and LBBAP. Clinicians should be aware of this potential, albeit rare, complication of LBBAP to ensure timely recognition and management. Increased awareness is vital for optimizing patient care during CSP procedures.
- 1 November 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (11) , ytae546
Open AccessTakotsubo syndrome induced by de novo left bundle branch area pacing: a case report
Takotsubo syndrome (TS), traditionally associated with emotional or physical stressors, manifests as transient left ventricular (LV) abnormalities mimicking acute coronary syndrome. Surgical procedures, such as pacemaker implantation, have emerged as potential TS triggers. Conduction system pacing (CSP), including His bundle pacing and left bundle branch area pacing (LBBAP), is a novel technique utilizing the heart's intrinsic conduction system. Despite documented cases of TS post-pacemaker implantation, the literature exploring the association between CSP and TS remains sparse. In a case involving a 62-year-old woman with 2:1 atrioventricular block, an uncomplicated de novo LBBAP procedure was followed by post-procedural dizziness and dyspnoea. An initial transthoracic echocardiography revealed moderate–severe LV dysfunction, accompanied by elevated troponin levels. Coronary angiography showed unobstructed coronary arteries, while left ventriculography exhibited a classic apical ballooning. The patient had a favourable recovery, with LV function improvement noted before discharge. Takotsubo syndrome may be triggered by other non-traditional physical stressors including traditional RV pacing and LBBAP. Clinicians should be aware of this potential, albeit rare, complication of LBBAP to ensure timely recognition and management. Increased awareness is vital for optimizing patient care during CSP procedures.
- Open Access
- 23 April 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (5) , ytae214
Compatibility of transvenous implantable cardioverter defibrillator and vagus nerve stimulation device: a case report
Background: Vagus nerve stimulation (VNS) is an established therapy for drug-resistant epilepsy and depression. While VNS co-existence with cardiac pacemakers is considered safe, its interaction with implantable cardioverter defibrillators (ICDs) remains poorly understood. The concern revolves around the potential for VNS stimulation to interfere with ICD function, potentially resulting in inappropriate therapy or changes in cardiac pacing. Case summary: We present the case of a 50-year-old woman with drug-resistant epilepsy who underwent VNS device implantation and subsequent transvenous ICD placement for primary prevention post-myocardial infarction. These devices were thoughtfully situated contralaterally, with a minimum 10 cm separation. Comprehensive testing and follow-up demonstrated no interactions during device programming or serial assessments. Simultaneous interrogation of both devices with their respective telemetry wands caused chaotic artefacts in all channels on the ICD, likely due to electromagnetic interference. Importantly, this interference did not affect ICD sensing. Discussion: The co-existence of VNS and ICD in a patient is an emerging scenario with limited previous reports, yet our findings align with prior cases involving VNS and pacemakers. Emphasizing the need for optimal device separation and meticulous evaluation, particularly at maximum VNS output and ICD sensitivity settings, ensures their safe and feasible co-existence. As the use of VNS alongside cardiac implantable electronic devices becomes more common, a diligent evaluation for potential interactions is imperative. Our case highlights the successful co-existence of VNS and ICD, underscoring the importance of careful monitoring and evaluation to guarantee the safe utilization of these two devices.
- 23 April 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (5) , ytae214
Open AccessCompatibility of transvenous implantable cardioverter defibrillator and vagus nerve stimulation device: a case report
Background: Vagus nerve stimulation (VNS) is an established therapy for drug-resistant epilepsy and depression. While VNS co-existence with cardiac pacemakers is considered safe, its interaction with implantable cardioverter defibrillators (ICDs) remains poorly understood. The concern revolves around the potential for VNS stimulation to interfere with ICD function, potentially resulting in inappropriate therapy or changes in cardiac pacing. Case summary: We present the case of a 50-year-old woman with drug-resistant epilepsy who underwent VNS device implantation and subsequent transvenous ICD placement for primary prevention post-myocardial infarction. These devices were thoughtfully situated contralaterally, with a minimum 10 cm separation. Comprehensive testing and follow-up demonstrated no interactions during device programming or serial assessments. Simultaneous interrogation of both devices with their respective telemetry wands caused chaotic artefacts in all channels on the ICD, likely due to electromagnetic interference. Importantly, this interference did not affect ICD sensing. Discussion: The co-existence of VNS and ICD in a patient is an emerging scenario with limited previous reports, yet our findings align with prior cases involving VNS and pacemakers. Emphasizing the need for optimal device separation and meticulous evaluation, particularly at maximum VNS output and ICD sensitivity settings, ensures their safe and feasible co-existence. As the use of VNS alongside cardiac implantable electronic devices becomes more common, a diligent evaluation for potential interactions is imperative. Our case highlights the successful co-existence of VNS and ICD, underscoring the importance of careful monitoring and evaluation to guarantee the safe utilization of these two devices.
- Open Access
- 6 February 2024
- Published by Elsevier in Heart Rhythm O2
- Vol. 5 (3) , 198-199
Ultrasound-guided explantation technique for implantable loop recorder in patients with high body mass index: a practical approach
- 6 February 2024
- Published by Elsevier in Heart Rhythm O2
- Vol. 5 (3) , 198-199
Open AccessUltrasound-guided explantation technique for implantable loop recorder in patients with high body mass index: a practical approach